# RDF export of group: Publication
<http://ctro/data#Publication_42320> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Publication> .
<http://ctro/data#Publication_42320> <http://www.w3.org/2000/01/rdf-schema#label> "Publication " .
<http://ctro/data#Publication_42320> <http://ctro/data#hasTitle> "Efficacy and safety of the dipeptidyl peptidase - 4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes : a 24 - week , multicenter , randomized , double - blind , placebo - controlled , parallel - group study ." .
<http://ctro/data#Publication_42320> <http://ctro/data#hasAuthor> "Rosenstock J" .
<http://ctro/data#Publication_42320> <http://ctro/data#hasPublicationYear> "2006" .
<http://ctro/data#Publication_42320> <http://ctro/data#hasJournal> "Clin Ther ." .
<http://ctro/data#Publication_42320> <http://ctro/data#hasPMID> "17157112" .
<http://ctro/data#Publication_42320> <http://ctro/data#describes> <http://ctro/data#ClinicalTrial_42331> .
<http://ctro/data#Publication_42320> <http://ctro/data#hasAuthor> "Brazg R" .
<http://ctro/data#Publication_42320> <http://ctro/data#hasAuthor> "Andryuk PJ" .
<http://ctro/data#Publication_42320> <http://ctro/data#hasAuthor> "Lu K" .
<http://ctro/data#Publication_42320> <http://ctro/data#hasAuthor> "Stein P" .
# RDF export of group: ClinicalTrial
<http://ctro/data#ClinicalTrial_42331> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#ClinicalTrial> .
<http://ctro/data#ClinicalTrial_42331> <http://www.w3.org/2000/01/rdf-schema#label> "ClinicalTrial " .
<http://ctro/data#ClinicalTrial_42331> <http://ctro/data#hasObjectiveDescription> "The efficacy and tolerability of the dipeptidyl peptidase - 4 inhibitor sitagliptin added to ongoing pioglitazone therapy" .
<http://ctro/data#ClinicalTrial_42331> <http://ctro/data#hasCTduration> "24 - week" .
<http://ctro/data#AllocationRatio_42335> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AllocationRatio> .
<http://ctro/data#ClinicalTrial_42331> <http://ctro/data#hasAllocationRatio> <http://ctro/data#AllocationRatio_42335> .
<http://ctro/data#CTAnalysisApproach_42336> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#CTAnalysisApproach> .
<http://ctro/data#ClinicalTrial_42331> <http://ctro/data#hasCTDesign> <http://ctro/data#Multicenter> .
<http://ctro/data#ClinicalTrial_42331> <http://ctro/data#hasArm> <http://ctro/data#Arm_42391> .
<http://ctro/data#ClinicalTrial_42331> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Type2Diabetes> .
<http://ctro/data#ClinicalTrial_42331> <http://ctro/data#hasPopulation> <http://ctro/data#Population_42353> .
<http://ctro/data#ClinicalTrial_42331> <http://ctro/data#hasDiffBetweenGroups> <http://ctro/data#DiffBetweenGroups_42497> .
<http://ctro/data#EvidenceQuality_42343> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EvidenceQuality> .
<http://ctro/data#ClinicalTrial_42331> <http://ctro/data#hasObjectiveDescription> "were assessed in patients with type 2 diabetes and inadequate glycemic control ( glycosylated hemoglobin [ HbA ( 1c ) ] > or = 7 % and < or = 10 % ) while receiving a stable dose of pioglitazone ." .
<http://ctro/data#ClinicalTrial_42331> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized> .
<http://ctro/data#ClinicalTrial_42331> <http://ctro/data#hasCTDesign> <http://ctro/data#DoubleBlind> .
<http://ctro/data#ClinicalTrial_42331> <http://ctro/data#hasCTDesign> <http://ctro/data#Parallel> .
<http://ctro/data#ClinicalTrial_42331> <http://ctro/data#hasCTDesign> <http://ctro/data#OpenLabel> .
<http://ctro/data#ClinicalTrial_42331> <http://ctro/data#hasCTDesign> <http://ctro/data#Blind> .
<http://ctro/data#ClinicalTrial_42331> <http://ctro/data#hasArm> <http://ctro/data#Arm_42400> .
<http://ctro/data#ClinicalTrial_42331> <http://ctro/data#hasDiffBetweenGroups> <http://ctro/data#DiffBetweenGroups_42506> .
<http://ctro/data#ClinicalTrial_42331> <http://ctro/data#hasDiffBetweenGroups> <http://ctro/data#DiffBetweenGroups_42623> .
# RDF export of group: Population
<http://ctro/data#Population_42353> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Population> .
<http://ctro/data#Population_42353> <http://www.w3.org/2000/01/rdf-schema#label> "Population " .
<http://ctro/data#Population_42353> <http://ctro/data#hasPrecondition> "type 2 diabetes and inadequate glycemic control ( glycosylated hemoglobin [ HbA ( 1c ) ] > or = 7 % and < or = 10 % ) while receiving a stable dose of pioglitazone" .
<http://ctro/data#Ethnicity_42355> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Ethnicity> .
<http://ctro/data#Population_42353> <http://ctro/data#hasCountry> <http://ctro/data#USA> .
<http://ctro/data#Population_42353> <http://ctro/data#hasMinAge> "18" .
<http://ctro/data#Gender_42360> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Gender> .
# RDF export of group: Endpoint
<http://ctro/data#Endpoint_42361> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_42361> <http://www.w3.org/2000/01/rdf-schema#label> "Endpoint hba1c" .
<http://ctro/data#Endpoint_42361> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#HbA1c> .
<http://ctro/data#Mean_42363> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean> .
<http://ctro/data#Endpoint_42361> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_42363> .
<http://ctro/data#Endpoint_42361> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Percentage> .
<http://ctro/data#MeasurementDevice_42365> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
<http://ctro/data#Endpoint_42366> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_42366> <http://www.w3.org/2000/01/rdf-schema#label> "Endpoint fpg" .
<http://ctro/data#Endpoint_42366> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#FastingPlasmaGlucose> .
<http://ctro/data#AggregationMethod_42368> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AggregationMethod> .
<http://ctro/data#Endpoint_42366> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Mg_per_deciliter> .
<http://ctro/data#MeasurementDevice_42370> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
<http://ctro/data#Endpoint_42371> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_42371> <http://www.w3.org/2000/01/rdf-schema#label> "Endpoint hba1c target" .
<http://ctro/data#Endpoint_42371> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#HbA1c_target> .
<http://ctro/data#AggregationMethod_42373> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AggregationMethod> .
<http://ctro/data#BioAndMedicalUnit_42374> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit> .
<http://ctro/data#MeasurementDevice_42375> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
<http://ctro/data#Endpoint_42376> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_42376> <http://www.w3.org/2000/01/rdf-schema#label> "Endpoint fspl" .
<http://ctro/data#EndPointDescription_42377> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription> .
<http://ctro/data#Endpoint_42376> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_42377> .
<http://ctro/data#AggregationMethod_42378> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AggregationMethod> .
<http://ctro/data#BioAndMedicalUnit_42379> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit> .
<http://ctro/data#MeasurementDevice_42380> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
<http://ctro/data#Endpoint_42381> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_42381> <http://www.w3.org/2000/01/rdf-schema#label> "Endpoint p/ir" .
<http://ctro/data#EndPointDescription_42382> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription> .
<http://ctro/data#Endpoint_42381> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_42382> .
<http://ctro/data#AggregationMethod_42383> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AggregationMethod> .
<http://ctro/data#BioAndMedicalUnit_42384> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit> .
<http://ctro/data#MeasurementDevice_42385> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
<http://ctro/data#Endpoint_42386> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_42386> <http://www.w3.org/2000/01/rdf-schema#label> "Endpoint h" .
<http://ctro/data#Endpoint_42386> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#Hypoglycemia> .
<http://ctro/data#AggregationMethod_42388> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AggregationMethod> .
<http://ctro/data#BioAndMedicalUnit_42389> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit> .
<http://ctro/data#MeasurementDevice_42390> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
# RDF export of group: Arm
<http://ctro/data#Arm_42391> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Arm> .
<http://ctro/data#Arm_42391> <http://www.w3.org/2000/01/rdf-schema#label> "Arm s + p " .
<http://ctro/data#Arm_42391> <http://ctro/data#hasNumberPatientsArm> "One hundred seventy - five" .
<http://ctro/data#Arm_42391> <http://ctro/data#hasIntervention> <http://ctro/data#Intervention_42409> .
<http://ctro/data#Arm_42391> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_42443> .
<http://ctro/data#Arm_42391> <http://ctro/data#hasAdverseEffect> <http://ctro/data#Outcome_42686> .
<http://ctro/data#Arm_42391> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_42515> .
<http://ctro/data#Arm_42391> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_42569> .
<http://ctro/data#Arm_42391> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_42632> .
<http://ctro/data#Arm_42391> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_42659> .
<http://ctro/data#Arm_42400> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Arm> .
<http://ctro/data#Arm_42400> <http://www.w3.org/2000/01/rdf-schema#label> "Arm pl + p " .
<http://ctro/data#Arm_42400> <http://ctro/data#hasNumberPatientsArm> "178" .
<http://ctro/data#Arm_42400> <http://ctro/data#hasIntervention> <http://ctro/data#Intervention_42416> .
<http://ctro/data#Arm_42400> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_42470> .
<http://ctro/data#Arm_42400> <http://ctro/data#hasAdverseEffect> <http://ctro/data#Outcome_42713> .
<http://ctro/data#Arm_42400> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_42542> .
<http://ctro/data#Arm_42400> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_42596> .
# RDF export of group: Intervention
<http://ctro/data#Intervention_42409> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Intervention> .
<http://ctro/data#Intervention_42409> <http://www.w3.org/2000/01/rdf-schema#label> "Intervention s + p" .
<http://ctro/data#Intervention_42409> <http://ctro/data#hasFrequency> "once daily" .
<http://ctro/data#RelativeTime_42414> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#RelativeTime> .
<http://ctro/data#Intervention_42409> <http://ctro/data#hasMedication> <http://ctro/data#Medication_42429> .
<http://ctro/data#Intervention_42416> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Intervention> .
<http://ctro/data#Intervention_42416> <http://www.w3.org/2000/01/rdf-schema#label> "Intervention pl + p " .
<http://ctro/data#RelativeTime_42421> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#RelativeTime> .
<http://ctro/data#Intervention_42416> <http://ctro/data#hasMedication> <http://ctro/data#Medication_42436> .
# RDF export of group: Medication
<http://ctro/data#Medication_42429> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Medication> .
<http://ctro/data#Medication_42429> <http://www.w3.org/2000/01/rdf-schema#label> "Medication s" .
<http://ctro/data#Medication_42429> <http://ctro/data#hasDrug> <http://ctro/data#Sitagliptin> .
<http://ctro/data#Medication_42429> <http://ctro/data#hasDoseValue> "100" .
<http://ctro/data#Medication_42429> <http://ctro/data#hasDoseUnit> <http://ctro/data#mg> .
<http://ctro/data#DeliveryMethod_42433> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DeliveryMethod> .
<http://ctro/data#Medication_42436> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Medication> .
<http://ctro/data#Medication_42436> <http://www.w3.org/2000/01/rdf-schema#label> "Medication pl" .
<http://ctro/data#Medication_42436> <http://ctro/data#hasDrug> <http://ctro/data#Placebo> .
<http://ctro/data#BioAndMedicalUnit_42439> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit> .
<http://ctro/data#DeliveryMethod_42440> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DeliveryMethod> .
# RDF export of group: Outcome
<http://ctro/data#Outcome_42443> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_42443> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome hba1c s " .
<http://ctro/data#Outcome_42443> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_42361> .
<http://ctro/data#Outcome_42443> <http://ctro/data#hasBaselineValue> "8 . 1" .
<http://ctro/data#Outcome_42443> <http://ctro/data#hasSdDevBL> "0 . 8" .
<http://ctro/data#Outcome_42443> <http://ctro/data#hasResultMeasuredValue> "7 . 2" .
<http://ctro/data#Outcome_42443> <http://ctro/data#hasSdDevResValue> "0 . 9" .
<http://ctro/data#Outcome_42443> <http://ctro/data#hasTimePoint> "After 24 weeks" .
<http://ctro/data#Outcome_42470> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_42470> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome hba1c pl" .
<http://ctro/data#Outcome_42470> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_42361> .
<http://ctro/data#Outcome_42470> <http://ctro/data#hasBaselineValue> "8 . 0" .
<http://ctro/data#Outcome_42470> <http://ctro/data#hasSdDevBL> "0 . 8" .
<http://ctro/data#Outcome_42470> <http://ctro/data#hasResultMeasuredValue> "7 . 8" .
<http://ctro/data#Outcome_42470> <http://ctro/data#hasSdDevResValue> "1 . 1" .
<http://ctro/data#Outcome_42470> <http://ctro/data#hasTimePoint> "After 24 weeks" .
<http://ctro/data#Outcome_42515> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_42515> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome fpg s" .
<http://ctro/data#Outcome_42515> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_42366> .
<http://ctro/data#Outcome_42542> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_42542> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome fpg pl" .
<http://ctro/data#Outcome_42542> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_42366> .
<http://ctro/data#Outcome_42569> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_42569> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome hba1c target s" .
<http://ctro/data#Outcome_42569> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_42371> .
<http://ctro/data#Outcome_42569> <http://ctro/data#hasPercentageAffected> "45 . 4" .
<http://ctro/data#Outcome_42596> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_42596> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome hba1c target pl " .
<http://ctro/data#Outcome_42596> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_42371> .
<http://ctro/data#Outcome_42596> <http://ctro/data#hasPercentageAffected> "23 . 0" .
<http://ctro/data#Outcome_42632> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_42632> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome fspl s" .
<http://ctro/data#Outcome_42632> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_42376> .
<http://ctro/data#Outcome_42632> <http://ctro/data#hasPValueChangeValue> "P < 0 . 01" .
<http://ctro/data#Outcome_42632> <http://ctro/data#hasObservedResult> "Significant reductions" .
<http://ctro/data#Outcome_42659> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_42659> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome p/ir s" .
<http://ctro/data#Outcome_42659> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_42381> .
<http://ctro/data#Outcome_42659> <http://ctro/data#hasPValueChangeValue> "P < 0 . 01" .
<http://ctro/data#Outcome_42659> <http://ctro/data#hasObservedResult> "Significant reductions" .
<http://ctro/data#Outcome_42686> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_42686> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome h s" .
<http://ctro/data#Outcome_42686> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_42386> .
<http://ctro/data#Outcome_42686> <http://ctro/data#hasNumberAffected> "2" .
<http://ctro/data#Outcome_42686> <http://ctro/data#hasObservedResult> "no increased risk" .
<http://ctro/data#Outcome_42713> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_42713> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome h pl" .
<http://ctro/data#Outcome_42713> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_42386> .
# RDF export of group: DiffBetweenGroups
<http://ctro/data#DiffBetweenGroups_42497> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DiffBetweenGroups> .
<http://ctro/data#DiffBetweenGroups_42497> <http://www.w3.org/2000/01/rdf-schema#label> "DiffBetweenGroups hba1c" .
<http://ctro/data#DiffBetweenGroups_42497> <http://ctro/data#hasDiffGroupAbsValue> "- 0 . 70" .
<http://ctro/data#DiffBetweenGroups_42497> <http://ctro/data#hasPvalueDiff> "P < 0 . 001" .
<http://ctro/data#DiffBetweenGroups_42497> <http://ctro/data#hasConfIntervalDiff> "95 % CI , - 0 . 85 to - 0 . 54" .
<http://ctro/data#DiffBetweenGroups_42497> <http://ctro/data#hasOutcome1> <http://ctro/data#Outcome_42443> .
<http://ctro/data#DiffBetweenGroups_42497> <http://ctro/data#hasOutcome2> <http://ctro/data#Outcome_42470> .
<http://ctro/data#DiffBetweenGroups_42506> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DiffBetweenGroups> .
<http://ctro/data#DiffBetweenGroups_42506> <http://www.w3.org/2000/01/rdf-schema#label> "DiffBetweenGroups fpg " .
<http://ctro/data#DiffBetweenGroups_42506> <http://ctro/data#hasDiffGroupAbsValue> "- 17 . 7" .
<http://ctro/data#DiffBetweenGroups_42506> <http://ctro/data#hasPvalueDiff> "P < 0 . 001" .
<http://ctro/data#DiffBetweenGroups_42506> <http://ctro/data#hasConfIntervalDiff> "95 % CI , - 24 . 3 to - 11 . 0" .
<http://ctro/data#DiffBetweenGroups_42506> <http://ctro/data#hasOutcome1> <http://ctro/data#Outcome_42515> .
<http://ctro/data#DiffBetweenGroups_42506> <http://ctro/data#hasOutcome2> <http://ctro/data#Outcome_42542> .
<http://ctro/data#DiffBetweenGroups_42623> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DiffBetweenGroups> .
<http://ctro/data#DiffBetweenGroups_42623> <http://www.w3.org/2000/01/rdf-schema#label> "DiffBetweenGroups hba1c target " .
<http://ctro/data#DiffBetweenGroups_42623> <http://ctro/data#hasPvalueDiff> "P < 0 . 001" .
<http://ctro/data#DiffBetweenGroups_42623> <http://ctro/data#hasOutcome1> <http://ctro/data#Outcome_42569> .
<http://ctro/data#DiffBetweenGroups_42623> <http://ctro/data#hasOutcome2> <http://ctro/data#Outcome_42596> .
# RDF export of group: EvidenceQuality